by Brandon Tudor | Jun 7, 2025 | Uncategorized
Recent news from Barcelona: As a function of the very first Global Think Tank on Steatotic Liver Disease, supported by the Barcelona Institute for Global Health (ISGlobal) and held in the Palau Macaya of Barcelona on June 5-6, 2025, 100+ international experts issued a...
by Brandon Tudor | Jun 5, 2025 | Uncategorized
An article recently published in Diabetes Care highlights the significant interplay between metabolic dysfunction–associated steatotic liver disease (MASLD) and type 2 diabetes. Summary– 🔄 Bidirectional Relationship Between MASLD and T2D Prevalence:...
by Brandon Tudor | Jun 3, 2025 | Uncategorized
Consider the article titled “Decompensated Liver Cirrhosis Care” from Gastroenterology & Endoscopy News (May 2025), which focuses on enhancing quality of life (QOL) and symptom management for patients with decompensated liver cirrhosis....
by Brandon Tudor | May 30, 2025 | Uncategorized
A recent study published in JAMA Surgery highlights the benefits of normothermic machine perfusion (NMP) in liver transplantation, particularly for organs from donation after circulatory death (DCD) donors. NMP involves preserving donor livers at body temperature with...
by Brandon Tudor | May 29, 2025 | Uncategorized
“The liver cirrhosis treatment market is poised for significant growth, driven by the rising global prevalence of liver diseases, particularly NAFLD, fueled by lifestyle factors like obesity, alcohol consumption, and metabolic syndrome. Technological...